Elevated plasma glucose-dependent insulinotropic polypeptide associates with hyperinsulinemia in metabolic syndrome

Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular disease

(2010) Minako Yamaoka-Tojo et al.   Cardiovascular Diabetology

Is the Diminished Incretin Effect in Type 2 Diabetes Just an Epi-Phenomenon of Impaired  -Cell Function?

(2010) J. J. Meier et al.   DIABETES

Excess Health Care Costs of Obesity in Adults with Diabetes Mellitus: a Claims Data Analysis

(2010) T. von Lengerke et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Early phase insulin secretion is increased in subjects with normal fasting glucose and metabolic syndrome: a premature feature of beta-cell dysfunction

(2010) L. Spadaro et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men

(2009) K. Pilgaard et al.   DIABETOLOGIA

Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin

(2009) Pernille Fog Svendsen et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Insulin Resistance and Hyperinsulinemia: Is hyperinsulinemia the cart or the horse?

(2008) M. H. Shanik et al.   DIABETES CARE